
|Articles|February 15, 2022
- Pharm Exec E-Books-03-08-2021
- Volume Sponsored eBook
- Issue 2
The Next Domino: Automation, AI, and touchless safety case processing
Author(s)Oracle
With the increasing volumes of adverse event reports and stagnant budgets, the time is now for a revolutionary change in drug and device safety case management. A robust management process is necessary for identifying and evaluating adverse events (AE) and reporting them properly to regulators.
Related Content
Trending on PharmExec
1
2026 Pharm Exec Top 50 Companies
2
M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration with Eli Lilly, Chugai and GSK Enter License Agreement for AID351
3
Pharmaceutical Executive Daily: Unpacking IRA-Driven Formulary Pressure
4
President Trump Set to Nominate Heidi Overton as FDA Commissioner
5